Diabetogenic action of 5-thio-D-glucopyranose in rats.
D000818:Animals; D003964:Diaphragm / Q000378:metabolism; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005947:Glucose / Q000378:metabolism; D005949:Glucose Oxidase; D006019:Glycolysis / Q000187:drug effects; D006029:Glycosuria / Q000139:chemically induced*; D006571:Heterocyclic Compounds / Q000037:antagonists & inhibitors / Q000378:metabolism / Q000494:pharmacology; D006593:Hexokinase; D006601:Hexoses / Q000037:antagonists & inhibitors / Q000378:metabolism / Q000494:pharmacology; D006943:Hyperglycemia / Q000139:chemically induced*; D007328:Insulin / Q000494:pharmacology; D007668:Kidney / Q000378:metabolism / Q000502:physiology; D007700:Kinetics; D008099:Liver / Q000378:metabolism*; D051381:Rats; D013455:Sulfur; D013997:Time Factors
D005230:Fatty Acids, Nonesterified; D006571:Heterocyclic Compounds; D006601:Hexoses; D007328:Insulin; D013455:Sulfur; D005949:Glucose Oxidase; D006593:Hexokinase; D005947:Glucose